Cargando…
Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective
Infused biologics, such as pegloticase, are a core component of managing uncontrolled gout, which is increasing in prevalence. Pegloticase is often the last line of therapy for patients with uncontrolled gout; therefore, achieving a successful course of treatment is critical. The infusion nurse'...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306337/ https://www.ncbi.nlm.nih.gov/pubmed/37406337 http://dx.doi.org/10.1097/NAN.0000000000000510 |
_version_ | 1785065914350174208 |
---|---|
author | Baxter, Britni Sanders, Shayla Patel, Shilpa A. Martin, Andrea West, Michael |
author_facet | Baxter, Britni Sanders, Shayla Patel, Shilpa A. Martin, Andrea West, Michael |
author_sort | Baxter, Britni |
collection | PubMed |
description | Infused biologics, such as pegloticase, are a core component of managing uncontrolled gout, which is increasing in prevalence. Pegloticase is often the last line of therapy for patients with uncontrolled gout; therefore, achieving a successful course of treatment is critical. The infusion nurse's role in patient education, serum uric acid monitoring, and patient medication compliance is essential for ensuring patient safety and maximizing the number of patients who benefit from a full treatment course of pegloticase. Infusion nurses are on the front lines with patients and need to be educated on potential negative effects associated with the medications they infuse, such as infusion reactions, as well as risk management methods like patient screening and monitoring. Further, patient education provided by the infusion nurse plays a large role in empowering the patient to become their own advocate during pegloticase treatment. This educational overview includes a model patient case for pegloticase monotherapy, as well as one for pegloticase with immunomodulation and a step-by-step checklist for infusion nurses to refer to throughout the pegloticase infusion process. A video abstract is available for this article at http://links.lww.com/JIN/A105. |
format | Online Article Text |
id | pubmed-10306337 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer Health, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103063372023-06-30 Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective Baxter, Britni Sanders, Shayla Patel, Shilpa A. Martin, Andrea West, Michael J Infus Nurs Features Infused biologics, such as pegloticase, are a core component of managing uncontrolled gout, which is increasing in prevalence. Pegloticase is often the last line of therapy for patients with uncontrolled gout; therefore, achieving a successful course of treatment is critical. The infusion nurse's role in patient education, serum uric acid monitoring, and patient medication compliance is essential for ensuring patient safety and maximizing the number of patients who benefit from a full treatment course of pegloticase. Infusion nurses are on the front lines with patients and need to be educated on potential negative effects associated with the medications they infuse, such as infusion reactions, as well as risk management methods like patient screening and monitoring. Further, patient education provided by the infusion nurse plays a large role in empowering the patient to become their own advocate during pegloticase treatment. This educational overview includes a model patient case for pegloticase monotherapy, as well as one for pegloticase with immunomodulation and a step-by-step checklist for infusion nurses to refer to throughout the pegloticase infusion process. A video abstract is available for this article at http://links.lww.com/JIN/A105. Wolters Kluwer Health, Inc. 2023-07-06 2023-07 /pmc/articles/PMC10306337/ /pubmed/37406337 http://dx.doi.org/10.1097/NAN.0000000000000510 Text en © 2023 The Authors. Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Features Baxter, Britni Sanders, Shayla Patel, Shilpa A. Martin, Andrea West, Michael Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective |
title | Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective |
title_full | Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective |
title_fullStr | Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective |
title_full_unstemmed | Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective |
title_short | Pegloticase in Uncontrolled Gout: The Infusion Nurse Perspective |
title_sort | pegloticase in uncontrolled gout: the infusion nurse perspective |
topic | Features |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306337/ https://www.ncbi.nlm.nih.gov/pubmed/37406337 http://dx.doi.org/10.1097/NAN.0000000000000510 |
work_keys_str_mv | AT baxterbritni pegloticaseinuncontrolledgouttheinfusionnurseperspective AT sandersshayla pegloticaseinuncontrolledgouttheinfusionnurseperspective AT patelshilpaa pegloticaseinuncontrolledgouttheinfusionnurseperspective AT martinandrea pegloticaseinuncontrolledgouttheinfusionnurseperspective AT westmichael pegloticaseinuncontrolledgouttheinfusionnurseperspective |